BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30877616)

  • 1. Role of Estrogen in Androgen-Induced Prostate Carcinogenesis in NBL Rats.
    Ozten N; Vega K; Liehr J; Huang X; Horton L; Cavalieri EL; Rogan EG; Bosland MC
    Horm Cancer; 2019 Jun; 10(2-3):77-88. PubMed ID: 30877616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal and genotoxic estrogen-androgen carcinogenesis in the NBL rat prostate: A role for aromatase.
    Bosland MC; Vega K; Horton L; Schlicht MJ
    Prostate; 2023 Jun; 83(9):823-830. PubMed ID: 36938936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of a DNA adduct detectable by 32P-postlabeling in the dorsolateral prostate of NBL/Cr rats treated with estradiol-17 beta and testosterone.
    Han X; Liehr JG; Bosland MC
    Carcinogenesis; 1995 Apr; 16(4):951-4. PubMed ID: 7728979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex steroids and prostate carcinogenesis: integrated, multifactorial working hypothesis.
    Bosland MC
    Ann N Y Acad Sci; 2006 Nov; 1089():168-76. PubMed ID: 17261765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A perspective on the role of estrogen in hormone-induced prostate carcinogenesis.
    Bosland MC
    Cancer Lett; 2013 Jun; 334(1):28-33. PubMed ID: 22939996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer.
    Montgomery B; Nelson PS; Vessella R; Kalhorn T; Hess D; Corey E
    BMC Cancer; 2010 May; 10():244. PubMed ID: 20509933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of diethylstilbestrol and estradiol-17 beta in combination with testosterone on rat prostate lobes.
    Ofner P; Bosland MC; Vena RL
    Toxicol Appl Pharmacol; 1992 Feb; 112(2):300-9. PubMed ID: 1539166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsomal hydroxylation of 2- and 4-fluoroestradiol to catechol metabolites and their conversion to methyl ethers: catechol estrogens as possible mediators of hormonal carcinogenesis.
    Ashburn SP; Han X; Liehr JG
    Mol Pharmacol; 1993 Apr; 43(4):534-41. PubMed ID: 8386306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delay of postnatal maturation sensitizes the mouse prostate to testosterone-induced pronounced hyperplasia: protective role of estrogen receptor-beta.
    Savolainen S; Pakarainen T; Huhtaniemi I; Poutanen M; Mäkelä S
    Am J Pathol; 2007 Sep; 171(3):1013-22. PubMed ID: 17640960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
    Carruba G
    J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen signaling and disruption of androgen metabolism in acquired androgen-independence during cadmium carcinogenesis in human prostate epithelial cells.
    Benbrahim-Tallaa L; Liu J; Webber MM; Waalkes MP
    Prostate; 2007 Feb; 67(2):135-45. PubMed ID: 17075824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual action of high estradiol doses on MNU-induced prostate neoplasms in a rodent model with high serum testosterone: Protective effect and emergence of unstable epithelial microenvironment.
    Gonçalves BF; de Campos SGP; Góes RM; Scarano WR; Taboga SR; Vilamaior PSL
    Prostate; 2017 Jun; 77(9):970-983. PubMed ID: 28401578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17 beta or diethylstilbestrol.
    Bosland MC; Ford H; Horton L
    Carcinogenesis; 1995 Jun; 16(6):1311-7. PubMed ID: 7788848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective increase in type II estrogen-binding sites in the dysplastic dorsolateral prostates of noble rats.
    Ho SM; Yu M
    Cancer Res; 1993 Feb; 53(3):528-32. PubMed ID: 7678774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catechol estrogen metabolites and conjugates in different regions of the prostate of Noble rats treated with 4-hydroxyestradiol: implications for estrogen-induced initiation of prostate cancer.
    Cavalieri EL; Devanesan P; Bosland MC; Badawi AF; Rogan EG
    Carcinogenesis; 2002 Feb; 23(2):329-33. PubMed ID: 11872641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor in rat skeletal muscle: characterization and physiological variations.
    Michel G; Baulieu EE
    Endocrinology; 1980 Dec; 107(6):2088-98. PubMed ID: 6968675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of estrogen supplementation on cell proliferation and expression of c-kit positive cells in the rat prostate.
    Kusljic S; Exintaris B
    Prostate; 2010 Oct; 70(14):1555-62. PubMed ID: 20687229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiestrogenic action of dihydrotestosterone in mouse breast. Competition with estradiol for binding to the estrogen receptor.
    Casey RW; Wilson JD
    J Clin Invest; 1984 Dec; 74(6):2272-8. PubMed ID: 6542571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen and estrogen receptor-mediated mechanisms of testosterone action in male rat pelvic autonomic ganglia.
    Purves-Tyson TD; Arshi MS; Handelsman DJ; Cheng Y; Keast JR
    Neuroscience; 2007 Aug; 148(1):92-104. PubMed ID: 17629410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of testosterone, dihydrotestosterone and estrogen on 3,2'-dimethyl-4-aminobiphenyl-induced rat prostate carcinogenesis.
    Shirai T; Imaida K; Masui T; Iwasaki S; Mori T; Kato T; Ito N
    Int J Cancer; 1994 Apr; 57(2):224-8. PubMed ID: 8157361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.